FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

443375003: Asenapine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2834710012 Asenapine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2838233016 Asenapine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
368191000195113 asenapina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
792331000172116 asénapine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
403001000274118 Asenapin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Asenapine (substance) Is a Atypical antipsychotic false Inferred relationship Some
Asenapine (substance) Is a Dopamine receptor antagonist true Inferred relationship Some
Asenapine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Dopamine receptor antagonist (disposition) true Inferred relationship Some
Asenapine (substance) Is a Heterocyclic compound true Inferred relationship Some
Asenapine (substance) Is a Anti-psychotic agent (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Asenapine 5 mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Asenapine (substance) Inferred relationship Some
Asenapine 10 mg sublingual tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Asenapine (substance) Inferred relationship Some
Product containing asenapine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Asenapine (substance) Inferred relationship Some 1
Asenapine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Asenapine (substance) Inferred relationship Some 1
Asenapine 5 mg sublingual tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Asenapine (substance) Inferred relationship Some 1
Asenapine 5 mg sublingual tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Asenapine (substance) Inferred relationship Some 1
Asenapine 10 mg sublingual tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Asenapine (substance) Inferred relationship Some 1
Asenapine 10 mg sublingual tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Asenapine (substance) Inferred relationship Some 1
Asenapine only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Asenapine (substance) Inferred relationship Some 1
Product containing asenapine in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Asenapine (substance) Inferred relationship Some 1
Asenapine only product in transdermal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Asenapine (substance) Inferred relationship Some 1
Product containing asenapine in transdermal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Asenapine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start